Search research articles
Contact Us
Filters
Showing results (61-70 of 223) with videos related to
Page
of 23
Sort By:
Clinical Advances in Hematology & Oncology : H&O
|
May 12, 2016
Discussion: Managing Risk When Using Idelalisib
Steven E Coutre, Jan A Burger, John M Pagel
Leukemia
|
December 18, 2018
The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia
Elisa Ten Hacken, Maria Gounari, Paolo Ghia, et al.
Leukemia & Lymphoma
|
July 3, 2020
Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection
Claudio Galvao de Castro, Lauro Jose Gregianin, Jan A Burger
Expert Review of Anticancer Therapy
|
April 21, 2011
Potential of CXCR4 antagonists for the treatment of metastatic lung cancer
Jan A Burger, David J Stewart, Ori Wald, et al.
Leukemia & Lymphoma
|
October 13, 2015
CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltrates
Elena M Hartmann, Martina Rudelius, Jan A Burger, et al.
Blood
|
July 29, 2009
The microenvironment in mature B-cell malignancies: a target for new treatment strategies
Jan A Burger, Paolo Ghia, Andreas Rosenwald, et al.
Blood
|
October 7, 2008
AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance
Kumudha Balakrishnan, Jan A Burger, William G Wierda, et al.
Expert Review of Hematology
|
November 13, 2014
Ibrutinib: a paradigm shift in management of CLL
Talha Badar, Jan A Burger, William G Wierda, et al.
Blood
|
August 5, 2006
CXCR4 is a prognostic marker in acute myelogenous leukemia
Anke C Spoo, Michael Lübbert, William G Wierda, et al.
Blood Research
|
July 3, 2018
Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As<sub>2</sub>O<sub>3</sub>) and all-trans retinoic acid (ATRA)
Preetesh Jain, Sergej Konoplev, Ohad Benjamini, et al.
Page
of 23
Search research articles
Search
Showing results (61-70 of 223) with videos related to
Sort By:
Page
of 23
Clinical Advances in Hematology & Oncology : H&O
|
May 12, 2016
Discussion: Managing Risk When Using Idelalisib
Steven E Coutre, Jan A Burger, John M Pagel
Leukemia
|
December 18, 2018
The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia
Elisa Ten Hacken, Maria Gounari, Paolo Ghia, et al.
Leukemia & Lymphoma
|
July 3, 2020
Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection
Claudio Galvao de Castro, Lauro Jose Gregianin, Jan A Burger
Expert Review of Anticancer Therapy
|
April 21, 2011
Potential of CXCR4 antagonists for the treatment of metastatic lung cancer
Jan A Burger, David J Stewart, Ori Wald, et al.
Leukemia & Lymphoma
|
October 13, 2015
CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltrates
Elena M Hartmann, Martina Rudelius, Jan A Burger, et al.
Blood
|
July 29, 2009
The microenvironment in mature B-cell malignancies: a target for new treatment strategies
Jan A Burger, Paolo Ghia, Andreas Rosenwald, et al.
Blood
|
October 7, 2008
AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance
Kumudha Balakrishnan, Jan A Burger, William G Wierda, et al.
Expert Review of Hematology
|
November 13, 2014
Ibrutinib: a paradigm shift in management of CLL
Talha Badar, Jan A Burger, William G Wierda, et al.
Blood
|
August 5, 2006
CXCR4 is a prognostic marker in acute myelogenous leukemia
Anke C Spoo, Michael Lübbert, William G Wierda, et al.
Blood Research
|
July 3, 2018
Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As<sub>2</sub>O<sub>3</sub>) and all-trans retinoic acid (ATRA)
Preetesh Jain, Sergej Konoplev, Ohad Benjamini, et al.
Page
of 23